
    
      The study is designed as a prospective, nonrandomized, exploratory, single center,
      first-in-man study. The objective of this study is to evaluate its safety and feasibility of
      the CinensesTM Lung Volume Reduction Reverser System in patients with severe emphysema. The
      study will also collect clinical data up to 6-month follow-up to explore its safety and
      effectiveness. Study Population ：Patients with severe emphysema and have to meet all the
      inclusion and exclusion criteria.

      Sample Size： 15 subjects
    
  